Effects of carvedilol on left ventricular remodeling and systolic function in elderly patients with heart failure. (Q44230621)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12453548%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

title

Effects of carvedilol on left ventricular remodeling and systolic function in elderly patients with heart failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12453548%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference

1 reference

1 reference

ventricular remodeling

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12453548%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

author name string

F Bruni

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12453548%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

L Puccetti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12453548%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

M Pastorelli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12453548%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

P Angori

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12453548%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

A L Pasqui

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12453548%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

A Auteri

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12453548%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

publication date

1 December 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12453548%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Heart Failure

15 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12453548%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12453548%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12453548%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

page(s)

765-770

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12453548%20AND%20SRC:MED&resulttype=core&format=json

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

15 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900114-9

Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900114-9

Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900114-9

Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900114-9

Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900114-9

Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900114-9

Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900114-9

Left ventricular volumes determined by two-dimensional echocardiography in a normal adult population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900114-9

Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900114-9

Adverse consequences of high sympathetic nervous activity in the failing human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900114-9

Tumor necrosis factor in CHF: a double facet cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900114-9

beta-adrenergic receptor blockade in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900114-9

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900114-9

Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900114-9

Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900114-9

Overview of the results of recent beta blocker trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900114-9

The Carvedilol Hibernation Reversible Ischaemia Trial; Marker of Success (CHRISTMAS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900114-9

Prognosis of left ventricular geometric patterns in the Framingham heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900114-9

Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900114-9

Carvedilol improves functional class in patients with severe left ventricular dysfunction referred for heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900114-9

Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900114-9

Echocardiographic features of primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900114-9

Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900114-9

Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900114-9

Changes in early and late diastolic filling patterns induced by long-term adrenergic beta-blockade in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900114-9

Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900114-9

Cardiac afferents and neurohormonal activation in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900114-9

Effects of carvedilol on left ventricular regional wall motion in patients with heart failure caused by ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900114-9

Efficacy of carvedilol on complex ventricular arrhythmias in dilated cardiomyopathy: double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900114-9

Sudden death in heart failure: vascular or electrical?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900114-9

Receptor pharmacology of carvedilol in the human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900114-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Major beta blocker mortality trials in chronic heart failure: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900114-9